Related Experiment Video

Updated: Apr 24, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.2K

Serum fetuin-A levels in patients with systolic heart failure

Mesut Keçebaş, Sümeyye Güllülü, Saim Sağ

    Acta Cardiologica
    |September 4, 2014
    PubMed

    Insights

    Serum fetuin-A levels are decreased in patients with chronic heart failure (CHF), suggesting reduced anti-inflammatory activity. This finding highlights fetuin-A

    Area of Science:

    • Cardiology
    • Biochemistry
    • Inflammation Research

    Background:

    • Cardiovascular disease (CVD) and chronic heart failure (CHF) are linked to inflammation and dystrophic calcification.
    • Fetuin-A is a protein involved in calcification and inflammation processes.

    Purpose of the Study:

    • To investigate the potential of serum fetuin-A as a biomarker for chronic heart failure (CHF).
    • To evaluate fetuin-A's diagnostic utility in systolic heart failure.

    Main Methods:

    • Serum fetuin-A levels were measured in 66 CHF patients and 31 healthy controls.
    • Fetuin-A was compared with C-reactive protein (CRP) and pro-brain natriuretic peptide (pro-BNP) as a diagnostic marker.

    Main Results:

    • Serum fetuin-A levels were significantly lower in CHF patients compared to controls (P < 0.01).
    • Serum fetuin-A demonstrated high sensitivity and specificity in identifying patients with systolic heart failure.

    Conclusions:

    • Decreased serum fetuin-A in CHF patients suggests downregulated anti-inflammatory activity.
    • Fetuin-A may play a role in the pathophysiology of CHF, potentially related to calcification processes.
    Abstract

    Related Concept Videos

    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    629
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    1.6K
    Heart Failure III: Clinical Manifestations01:26

    Heart Failure III: Clinical Manifestations

    Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
    1.0K
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    4.6K
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    836
    Serum Studies: Renal Function Tests01:24

    Serum Studies: Renal Function Tests

    Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
    669